Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana

Background. Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection has emerged as an important cause of morbidity and mortality. We determined the response to Truvada-based first-line combination antiretroviral therapy (cART) in HIV/HBV-coinfected verus HIV-monoinfected patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Anderson, Motswedi, Gaseitsiwe, Simani, Moyo, Sikhulile, Thami, Kerapetse P., Mohammed, Terence, Setlhare, Ditiro, Sebunya, Theresa K., Powell, Eleanor A., Makhema, Joseph, Blackard, Jason T., Marlink, Richard, Essex, Max, Musonda, Rosemary M.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5084712/
https://ncbi.nlm.nih.gov/pubmed/27800524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars